WallStreetZenWallStreetZen

NASDAQ: MLYS
Mineralys Therapeutics Inc Stock Ownership - Who owns Mineralys Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Mineralys Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David Malcom RodmanMed2026-08-102,170$16.00
$34.72kBuy
David Malcom RodmanMed2026-08-102,170$27.09
$58.79kSell
Eric WarrenCCO2026-07-217,438$26.87
$199.88kSell
Eric WarrenCCO2026-07-217,438$13.24
$98.48kBuy
David Malcom RodmanMed2026-07-17416$15.44
$6.42kBuy
David Malcom RodmanMed2026-07-17416$26.53
$11.04kSell
David Malcom RodmanChief2026-07-156,349$26.61
$168.95kSell
Jon CongletonCEO2026-07-1310,700$27.24
$291.45kSell
David Malcom RodmanChief2026-07-133,542$10.20
$36.13kBuy
David Malcom RodmanChief2026-07-134,167$14.25
$59.38kBuy

1 of 15

MLYS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MLYS insiders and whales buy or sell their stock.

MLYS Shareholders

What type of owners hold Mineralys Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Srinivas Akkaraju13.73%12,140,369$328.40MInsider
Samsara Biocapital GP LLC12.16%10,749,832$290.78MInsider
Brian Taylor Slingsby8.95%7,910,038$213.97MInsider
Catalys Pacific LLC8.94%7,903,838$213.80MInstitution
Ra Capital Management LP8.70%7,692,750$208.09MInstitution
Samsara Biocapital LLC6.64%5,871,018$158.81MInstitution
Fmr LLC5.50%4,861,104$131.49MInstitution
Blackrock Inc5.07%4,481,582$121.23MInstitution
Ra Capital Management LP4.22%3,734,458$101.02MInsider
Wellington Management Group LLP3.80%3,359,068$90.86MInstitution

1 of 3

MLYS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MLYS70.05%29.95%Net BuyingNet Selling
PGEN31.33%68.67%Net SellingNet Selling
KLRA0.00%85.31%Net BuyingNet Buying
VCEL91.39%8.61%Net SellingNet Selling
RAPP77.53%22.47%Net SellingNet Selling
View Top Biotech Stocks

Mineralys Therapeutics Stock Ownership FAQ

Who owns Mineralys Therapeutics?

Mineralys Therapeutics (NASDAQ: MLYS) is owned by 102.17% institutional shareholders, 43.69% Mineralys Therapeutics insiders, and 0.00% retail investors. Srinivas Akkaraju is the largest individual Mineralys Therapeutics shareholder, owning 12.14M shares representing 13.73% of the company. Srinivas Akkaraju's Mineralys Therapeutics shares are currently valued at $316.74M.

If you're new to stock investing, here's how to buy Mineralys Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.